EGFR A859S alteration may predict a better response to third-generation EGFR-TKI treatment in advanced NSCLC.

ABSTRACT:

SUBMITTER: Hong W 

PROVIDER: S-EPMC12451320 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature